Genotoxic Impurities Summit 2025:
The Transformation of Pharmaceutical Safety Through Science and Regulation
The Transformation of Pharmaceutical Safety Through Science and Regulation
The 3rd Annual Genotoxic Impurities Summit is a premier event uniting experts from pharmaceutical companies, regulatory agencies, and toxicology research.
Focusing on critical topics such as nitrosamines control, ICH M7 updates, DNA-reactive impurities, and advanced genotoxic risk assessment strategies, this summit is the ideal platform for professionals aiming to stay ahead in impurity management and enhance pharmaceutical safety standards.
Focusing on critical topics such as nitrosamines control, ICH M7 updates, DNA-reactive impurities, and advanced genotoxic risk assessment strategies, this summit is the ideal platform for professionals aiming to stay ahead in impurity management and enhance pharmaceutical safety standards.
Lhasa principal scientist Michael Burns will be presenting Industrial case studies of purge to support N-nitrosamine control strategies, a presentation that will summarise findings in our recently published OPRD article.
Attendance can be either online or in person, register to secure your spot!